Details

Portfolio

Advancing Portfolio

Screening Program

Project Completed

RFP Year
2017
Awarded Amount
$65,836
Disease
Malaria
Intervention
Drug
Development Stage
Hit Identification
Collaboration Partners
Astellas Pharma Inc., Medicines for Malaria Venture (MMV)